检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:吴志奎[1] 张新华[2] 李敏[1] 柴立民[1] 刘咏梅[1] 王荣新[2] 蔡辉国[3] 黄有文[2] 易杰[4] 王蕾[1] 方素萍[1] 陈智松[1] 朱欲英[2] 陈玉英[1] 吕鑫霞[1]
机构地区:[1]中国中医科学院广安门医院分子生物学研究室,北京100053 [2]中国人民解放军第303医院 [3]中国医学科学院血液学研究所 [4]辽宁中医学院
出 处:《中国中西医结合杂志》2006年第4期352-354,共3页Chinese Journal of Integrated Traditional and Western Medicine
基 金:国家自然科学基金项目(No.30171199);国家自然科学基金重大研究计划(No.90409003)
摘 要:目的研究益髓生血颗粒治疗β-地中海贫血临床效果及安全性。方法在广西高发区用益髓生血颗粒治疗β-地中海贫血,疗程3个月,观察治疗前后临床症状、Hb、RBC、网织红细胞(Ret)、抗碱血红蛋白(HbF)水平变化并进行停药后3~6个月随访及不良反应的观察。结果治疗组患者自疗程第1个月起至3个月结束,Hb、RBC、Ret、HbF等各项血液学参数均有提高,与治疗前比较差异有显著性(P<0.01);中医临床症状改善及动态观察与血液参数提高相一致,与治疗前比较差异有显著性(P<0.01);156例中有效145例,无效11例,总有效率达92.9%。未见明显的不良反应。停药后随访结果显示,疗效维持时间3~4个月。结论益髓生血颗粒治疗β-地中海贫血疗效显著,未见明显的不良反应。为中医药辨证治疗β-地中海贫血提供了一定的依据。Objective To study the clinical effect and security of Yisui Shengxue Granule (YSG) in treating β-thalassemia. Methods One hundred and fifty-five patients with β-thalassemia from high-incidence area in Guangxi Zhuang Autonomous Region were treated with YSG for 3 months. Clinical symptoms and levels of hemoglobin (Hb), red blood cell (RBC), reticulocyte (Ret) and hemoglobin F (HbF) were observed before and after treatment, and the adverse reaction occurred in the therapeutic course was observed as well. A 3-6 months follow-up study was performed after withdrawal of YSG. Results Levels of Hb, RBC, Ret and HbF obviously elevated, and clinical symptoms markedly improved in patients after treatment since the 1st month to the 3rd month (all P 〈 0.01 ). Dynamical observation showed that the improvement of symptoms was in accordance with the elevation of hemorrheological indexes. The treatment was effective in 145 patients and ineffective in 11, and the total effective rate being 92.9 %, without any adverse reaction occurred. Follow-up study showed the therapeutic effect could be sustained for 3 to 4 months. Conclusion YSG has evident effect on β-thalassemia without obvious adverse reaction, which provides a definite basis for treatment of β-thalassemia with TCM.
分 类 号:R259[医药卫生—中西医结合]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.254